scispace - formally typeset
K

Karel Pacak

Researcher at National Institutes of Health

Publications -  704
Citations -  42875

Karel Pacak is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pheochromocytoma & Paraganglioma. The author has an hindex of 97, co-authored 643 publications receiving 36185 citations. Previous affiliations of Karel Pacak include University of Colorado Denver & MedStar Washington Hospital Center.

Papers
More filters
Journal ArticleDOI

Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline

TL;DR: This evidence-based guideline recommends minimally invasive adrenalectomy for most pheochromocytomas with open resection for most paragangliomas and suggests personalized management with evaluation and treatment by multidisciplinary teams with appropriate expertise to ensure favorable outcomes.
Journal ArticleDOI

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A Hoadley, +738 more
- 05 Apr 2018 - 
TL;DR: Molecular similarities among histologically or anatomically related cancer types provide a basis for focused pan-cancer analyses, such as pan-gastrointestinal, Pan-gynecological, pan-kidney, and pan-squamous cancers, and those related by stemness features, which may inform strategies for future therapeutic development.
Journal ArticleDOI

Biochemical diagnosis of pheochromocytoma: which test is best?

TL;DR: Plasma free metanephrines provide the best test for excluding or confirming pheochromocytoma and should be the test of first choice for diagnosis of the tumor.
Journal ArticleDOI

Stressor specificity of central neuroendocrine responses: implications for stress-related disorders.

TL;DR: This review focuses mainly on the similarities and differences between the neuroendocrine responses (especially the sympathoadrenal and the sympathoneuronal systems and the hypothalamo-pituitary-adrenocortical axis) among various stressors and a strategy for testing Selye's doctrine of nonspecificity.
Journal ArticleDOI

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor, +732 more
- 09 Apr 2018 - 
TL;DR: The genomic and phenotypic correlates of cancer aneuploidy are defined and genome engineering is applied to delete 3p in lung cells, causing decreased proliferation rescued in part by chromosome 3 duplication.